Market Recap — July 21, 2026
Today's running recap of insider activity, SEC filings, and market-moving news. Updates throughout the trading day.
Last updated Jul 21, 2026, 10:13 AM ET · updates through the trading day
Top Importance Today
Filings and news with the highest AI-ranked importance score.
Utz Brands Lays Out Financing and Governance for $2.9B Intersnack Buyout at $14.25/Share
Utz Brands to Go Private in $2.9B Deal with Intersnack Group at $14.25/Share, a 91% Premium
Intersnack to Buy Utz for $14.25/Share Cash, 87% Premium
KORE Completes Take-Private Merger at $9.25/Share, Refinances Debt with $325M Facility
BGM Group 20-F Discloses $19.9M Loss, Material Weakness, Nasdaq Bid Price Deficiency, and a $12M Dilutive Placement
PolyPid Inks $320M+ D-PLEX100 Deal with Azurity, Adding Royalties and Manufacturing Revenue
Alpha Tau Reports 100% ORR and 18.2-Month OS in Head and Neck Cancer Combo Trial
Alpha DaRT + Keytruda Achieves 100% Response Rate in Head and Neck Cancer Trial
Pampa Energy's $4.5B Vaca Muerta Project Gets RIGI Approval, Targets $17B in Exports
PolyPid Secures $30M Upfront in $320M+ D-PLEX 100 Deal with Azurity
GM Beats Q2 Estimates, Raises 2026 Guidance Again, Declares Dividend
GM Q2 Core Profit Jumps 30% on Truck, SUV Strength; Raises 2026 Outlook
Largest Open-Market Insider Buys
Form 4 open-market purchases ranked by dollar amount.
No open-market insider buys reported on this date.
Largest Open-Market Insider Sells
Form 4 open-market sales ranked by dollar amount.
No open-market insider sells reported on this date.
Notable 8-Ks and News
Material events and breaking news with importance score 6 or higher.
Utz Brands to Go Private in $2.9B Deal with Intersnack Group at $14.25/Share, a 91% Premium
Intersnack to Buy Utz for $14.25/Share Cash, 87% Premium
KORE Completes Take-Private Merger at $9.25/Share, Refinances Debt with $325M Facility
PolyPid Inks $320M+ D-PLEX100 Deal with Azurity, Adding Royalties and Manufacturing Revenue
Alpha DaRT + Keytruda Achieves 100% Response Rate in Head and Neck Cancer Trial
GM Beats Q2 Estimates, Raises 2026 Guidance Again, Declares Dividend
GM Q2 Core Profit Jumps 30% on Truck, SUV Strength; Raises 2026 Outlook
BlackRock's GIP Closes $40B Aligned Data Centers Buy, Adds $5B Growth Capital
Horizon Aircraft Signs $600M LOI for 100 Hybrid eVTOLs with V-Star
Judge Halts $110B Paramount-WBD Merger; States Sue, Fees Revealed
Form 144 Notices
Notices that restricted shares may be sold soon — often a precursor to insider selling.
No Form 144 notices filed on this date.
Day boundary: 00:00 ET (America/New_York). Filings accepted late may appear in the next day's recap.